Noradrenaline and Parkinson's disease
Parkinson’s disease (PD) is characterized by the degeneration of dopamine (DA) neurons in the substantia nigra pars compacta, and motor symptoms including bradykinesia, rigidity and tremor at rest. These symptoms are manifest when around 70% of striatal DA is lost. In addition to motor deficits, PD...
Main Authors: | Claire eDelaville, Philippe eDe Deurwaerdère, Abdelhamid eBenazzouz |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2011-05-01
|
Series: | Frontiers in Systems Neuroscience |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fnsys.2011.00031/full |
Similar Items
-
The Noradrenergic System in Parkinson’s Disease
by: Elena Paredes-Rodriguez, et al.
Published: (2020-04-01) -
Emerging dysfunctions consequent to combined monoaminergic depletions in parkinsonism
by: Claire Delaville, et al.
Published: (2012-02-01) -
Lead-Induced Atypical Parkinsonism in Rats: Behavioral, Electrophysiological, and Neurochemical Evidence for a Role of Noradrenaline Depletion
by: Mariam Sabbar, et al.
Published: (2018-03-01) -
A role for locus coeruleus in Parkinson tremor
by: Ioannis Ugo eIsaias, et al.
Published: (2012-01-01) -
Dopamine and Noradrenaline in the Brain; Overlapping or Dissociate Functions?
by: Yadollah Ranjbar-Slamloo, et al.
Published: (2020-01-01)